Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA
source: pixabay.com

Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA

According to a recent story from pm360online.com, the pharmaceutical company Shire announced that the marketing application for its drug product lanadelumab has gained approval from the European Medicines Agency (EMA).…

Continue Reading Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA
An Experimental Drug Was Helping A Girl With Dravet Syndrome. Will She Lose Access After the Trial?
source: pixabay.com

An Experimental Drug Was Helping A Girl With Dravet Syndrome. Will She Lose Access After the Trial?

According to a recent story from CityNews Toronto, Alara Ozkose's Dravet syndrome was preventing her from being able to live a life that was even close to normal. She was…

Continue Reading An Experimental Drug Was Helping A Girl With Dravet Syndrome. Will She Lose Access After the Trial?
Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU
source: pixabay.com

Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU

According to a story from mrknewsroom.com, the pharmaceutical companies Merck and AstraZeneca recently announced that the marketing application for the investigational drug olaparib (brand name Lynparza) was recently certified for…

Continue Reading Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU
Patient Deaths While Taking Hemlibra Have Been Linked to Other Causes, Investigators Say
source: pixabay.com

Patient Deaths While Taking Hemlibra Have Been Linked to Other Causes, Investigators Say

According to a story from biopharmadive.com, the pharmaceutical company Roche is reporting a total of five deaths of patients with hemophilia A that have taken the company's product Hemlibra. While…

Continue Reading Patient Deaths While Taking Hemlibra Have Been Linked to Other Causes, Investigators Say
Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation
source: pixabay.com

Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation

According to a story from 4-traders.com, the pharmaceutical company SteroTherapeutics recently announced that its drug candidate ST-002 was awarded Orphan Drug Designation by the U.S. Food and Drug Administration (FDA).…

Continue Reading Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation

Here’s What You Should Know Before Taking 23andMe’s BRCA-Mutated Breast Cancer Test

According to a story from sunmag.net, 23andMe, the genetics testing company widely known for its ancestral analysis measures, is now offering a genetics test to measure your risk of BRCA1…

Continue Reading Here’s What You Should Know Before Taking 23andMe’s BRCA-Mutated Breast Cancer Test
New Discovery Could Lead to New Treatments for Cancers Linked to the Epstein-Barr Virus
source: pixabay.com

New Discovery Could Lead to New Treatments for Cancers Linked to the Epstein-Barr Virus

According to an article from VCU Massey Center's blog, a team of researchers from the VCU Massey Cancer Center have successfully discovered a pair of genes that could be essential for…

Continue Reading New Discovery Could Lead to New Treatments for Cancers Linked to the Epstein-Barr Virus
Genetic Testing is Necessary to Avoid Nerve-Damaging Chemotherapy for Patients With Charcot-Marie-Tooth Disease
source: pixabay.com

Genetic Testing is Necessary to Avoid Nerve-Damaging Chemotherapy for Patients With Charcot-Marie-Tooth Disease

A story from Charcot-Marie-Tooth News highlights the necessity for genetic testing and a physical examination prior to chemotherapy in order to prevent nerve damage in people with asymptomatic Charcot-Marie-Tooth disease…

Continue Reading Genetic Testing is Necessary to Avoid Nerve-Damaging Chemotherapy for Patients With Charcot-Marie-Tooth Disease
Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
Source: Pixabay

Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials

According to a story from SMA News Today, a recent study has demonstrated that the parents of children with spinal muscular atrophy are often skeptical about enrolling their kids in…

Continue Reading Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
This Gene Could Play a Major Role in Progressive Supranuclear Palsy
source: pixabay.com

This Gene Could Play a Major Role in Progressive Supranuclear Palsy

According to a story from asianscientist.com, a group of Japanese researchers have managed to unearth a genetic mutation that is associated with progressive supranuclear palsy. The discovery is helping scientists…

Continue Reading This Gene Could Play a Major Role in Progressive Supranuclear Palsy
TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says
Source: pixabay.com

TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says

According to an article from Righting Injustice, a recent study suggests that TNF inhibitors may increase the risk of rare cancers in pediatric patients. The study recommends that children that…

Continue Reading TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says
A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need
source: pixabay.com

A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need

An article from SRN News is reporting that a lot of people with familial hypercholesterolemia are going through life without getting the treatments that could help them, such as statins.…

Continue Reading A Lot of People With Familial Hypercholesterolemia Are Not Getting The Treatment They Need